Ortoma Launches AI-Based Software Platform for Implant Surgery

Ortoma AB is launching an artificial intelligence-based software platform that aims to improve surgical accuracy.

The company’s Ortoma Treatment Solution (OTS) has marketing approval in both Europe and the United States. OTS 5 has been developed for use with surgical instruments and includes a large number of improvements to existing functionalities and various new ones. The new version improves usability both before and after surgery, and includes an Ortoma Plan and Ortoma Guide.  

“OTS makes it possible for the surgeon to plan in 3D with high accuracy prior to surgery, and during surgery get assistance with correct placement of the implant in the patient. The system is aimed at providing better patient outcomes, fewer complications and less follow-up surgeries – and thus better long-term survival rates for the implant. The system can easily be integrated into the processes and routines that are currently used in surgeries,” said Gunnar Németh, board chairman of Ortoma, professor emeritus, and former head of Orthopedic Surgery at Karolinska University Hospital and Karolinska Institute.

Accessories to OTS have been developed to help reduce surgery time and increase the value proposition of the OTS platform. The launch, which includes additional functionality compared to the original scope, follows the company’s planned timeline despite the ongoing Covid-19 pandemic situation. In parallel with the development, the company is in discussions with potential commercialization partners globally.
 
OTS 5 is the result of development of, primarily, software and hardware during the greater part of this year. Market needs have continuously been integrated into the development process. Development of accessories to OTS was initiated last year and includes advanced product requirements and extensive regulatory requirements. 
  
In the software Ortoma Plan, which is used before surgery, workflows have been improved and functionality added. The system now includes, for example, an optimized algorithm based on artificial intelligence to assist the surgeon to select implant and optimize its position in a shorter time. 
 
In Ortoma Guide, which is used during surgery, both software and the new accessories to OTS, which are used with the surgical instruments, have been improved. The workflow in the software has been optimized to be more intuitive. The new accessories to OTS reduce the time for preparing for surgery significantly. Furthermore, the accessories can be produced in large volumes at low cost, which substantially increases the competitiveness of the system. 
 
“OTS 5 is the result of feedback from clinical partners and market research identifying the needs of potential commercialization partners. We are convinced that the updated platform will have a big impact on both patients and care providers globally. In addition, all parts of the system can now be sold at very competitive prices. I am proud that we have completed this launch during the ongoing pandemic, with increased scope and within the original planned timeline. Our staff has done a great job,” said Linus Byström, CEO of Ortoma. 
 
OTS 5 is an integrated surgical system for orthopedic implants and is designed for improved surgical results for the patient, with less complications and reduced number of reoperations – thereby also providing improved long term survival of the implant. The system can easily be integrated into existing processes for routine surgeries – and thereby increase efficiency. The system is developed as a platform for surgeries with orthopedic implants, and has marketing approval for hip replacement surgeries in Europe and USA. Ortoma is in discussion with potential commercialization partners globally.